UBS Group’s Global X China Biotech Innovation ETF CHB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23
| Closed | -$186 | – | 8942 |
|
|
2023
Q4 | $186 | Sell |
23
-1,235
| -98% | -$9.99K | ﹤0.01% | 7617 |
|
|
2023
Q3 | $9.51K | Buy |
+1,258
| New | +$9.51K | ﹤0.01% | 5996 |
|
|
2023
Q1 | – | Sell |
-1,538
| Closed | -$14.5K | – | 9479 |
|
|
2022
Q4 | $14.5K | Sell |
1,538
-25
| -2% | -$236 | ﹤0.01% | 6881 |
|
|
2022
Q3 | $13K | Buy |
1,563
+1,361
| +674% | +$11.3K | ﹤0.01% | 6994 |
|
|
2022
Q2 | $2K | Buy |
+202
| New | +$2K | ﹤0.01% | 8631 |
|
|
2022
Q1 | – | Sell |
-1,749
| Closed | -$25K | – | 9843 |
|
|
2021
Q4 | $25K | Sell |
1,749
-186
| -10% | -$2.66K | ﹤0.01% | 6486 |
|
|
2021
Q3 | $31K | Buy |
1,935
+1,056
| +120% | +$16.9K | ﹤0.01% | 5606 |
|
|
2021
Q2 | $17K | Buy |
+879
| New | +$17K | ﹤0.01% | 6439 |
|
|
2021
Q1 | – | Sell |
-1,205
| Closed | -$20K | – | 8336 |
|
|
2020
Q4 | $20K | Buy |
+1,205
| New | +$20K | ﹤0.01% | 5947 |
|